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Abstract
Background: The morphopathological picture of a subset of equine myopathies is compatible
with a primary mitochondrial disease, but functional confirmation in vivo is still pending. The
cationic dye JC-1 exhibits potential-dependent accumulation in mitochondria that is detectable by
a fluorescence shift from green to orange. As a consequence, mitochondrial membrane potential
can be optically measured by the orange/green fluorescence intensity ratio. A flow cytometric
standardized analytic procedure of the mitochondrial function of equine peripheral blood
mononuclear cells is proposed along with a critical appraisal of the crucial questions of technical
aspects, reproducibility, effect of time elapsed between blood sampling and laboratory processing
and reference values.
Results: The JC-1-associated fluorescence orange and green values and their ratio were proved
to be stable over time, independent of age and sex and hypersensitive to intoxication with a
mitochondrial potential dissipator. Unless time elapsed between blood sampling and laboratory
processing does not exceed 5 hours, the values retrieved remain stable. Reference values for
clinically normal horses are given.
Conclusion:  Whenever a quantitative measurement of mitochondrial function in a horse is
desired, blood samples should be taken in sodium citrate tubes and kept at room temperature for
a maximum of 5 hours before the laboratory procedure detailed here is started. The hope is that
this new test may help in confirming, studying and preventing equine myopathies that are currently
imputed to mitochondrial dysfunction.
Background
Equine atypical myopathy affects horses and ponies kept
on pasture and not exercised either prior to or at the time
of the first clinical signs. All cases have been reported in
the springtime or autumn and after a sudden drop in the
minimum daily temperature [1,2]. Affected horses are
usually well and suddenly display signs of acute myopa-
thy (stiffness, muscle pain, muscle fasciculations, abnor-
mal gait, recumbency, myoglobinuria, tachycardia,
sweating), with no hyperthermia and unchanged appetite
[3]. Unlike the other types of myopathy, this condition is
often fatal within 12 to 72 hours. Blood analysis consist-
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ently shows a spectacular increase in muscle enzymes, in
particular the creatine-kinases [3]. Recently, a detailed
macroscopical, histopathological, enzymohistochemical
and ultrastructural study of 32 clinical cases was reported
[2]. The morphopathological picture of the disease sug-
gested a mitochondrial disorder the characteristics of
which are compatible with those of equine toxic myopa-
thies due to plant, bacterial or fungal toxins [4-9].
Although morphologic clues of mitochondrial dysfunc-
tion in these equine diseases have accumulated, a func-
tional confirmation is still pending. Also, as the clinical
diagnosis is only possible late in the course of these dis-
eases, when definitive lesions have occurred, an early
marker is crucially needed to improve the clinical progno-
sis of established cases and to detect subclinical cases that
would benefit of preventive measures. Epidemiological
studies aimed at delineating the precise environmental
conditions that increase the risk of developing atypical
myopathy would also gain from a standardized laboratory
test that lends itself to mass screening. Therefore, reliable
methods for the sensitive determination of a possible
alteration of mitochondrial function in equine tissues are
desirable.
The cationic dye JC-1 exhibits potential-dependent accu-
mulation in mitochondria, indicated by a fluorescence
shift from green (~529 nm) to orange (~590 nm). This
potential-sensitive color shift is due to the concentration-
dependent intramitochondrial formation of orange fluo-
rescent oligomers [10-12]. As a consequence, mitochon-
drial membrane potential (∆ψm) can be optically
measured by the orange/green fluorescence intensity
ratio. This ratio is dependent only on the ∆ψm and not on
other factors such as mitochondrial size, shape, and den-
sity, which renders JC-1 far more reliable than any other
single-component fluorescence signals to evaluate mito-
chondrial function. JC-1 orange-green fluorescence ratio
has been used as an indicator of mitochondrial potential
in isolated mitochondria [13] but also in intact tissues
[14], spermatozoa [15] and cell lines, including myocytes
[12] and neurons [16]. Very subtle heterogeneity in cellu-
lar responses were already discerned in this way
[11,13,16], the most widely implemented application
being for detection of mitochondrial depolarization
occurring during apoptosis [17-20]. This series of studies
prompted us to suggest that JC-1-associated orange/green
ratio could function as a marker of mitochondrial dys-
function in the clinic. Since mitochondrial dysfunction
precedes morphologic alterations, it would permit an
early diagnosis of mitochondria-associated rhabdomy-
olyses in horses. Although muscle biopsies would directly
target the tissue of choice, questions remains about the
muscle to be sampled [2]. Furthermore, multiple biopsies
should be avoided in the routine clinic due to animal wel-
fare concerns. These practical considerations led us to
evaluate the candidature of JC-1 as an indicator of mito-
chondrial potential in equine peripheral blood mononu-
clear cells. In this paper, a standardized analytic procedure
is proposed along with a critical appraisal of the crucial
questions of reproducibility, effect of time elapsed
between blood sampling and laboratory processing and
reference values.
Results
Flow cytometric analysis of physical characteristics of
equine PBMC, using forward (FSC) and side (SSC) scat-
ters, consistently revealed two distinct subpopulations
(Fig. 1). The first is characterized by low FSC and SSC and
presumably corresponds to lymphocytes. Subsequent
analysis of fluorescent labelling of PBMC using appropri-
ate monoclonal antibodies confirmed that this popula-
tion indeed consisted of lymphocytes. The second
subpopulation, showing slightly higher FSC and SSC, is
rather compatible with monocytes. Because the first sub-
population was always less scattered than the second, it
was chosen to gate the cell subpopulation of which the JC-
1-associated fluorescences were studied.
Using 488 nm Sapphire™ solid-state laser excitation, the
gated nonstained cell populations showed readily identi-
fiable and very homogeneous autofluorescent emissions
within the 530/30 and 585/42 nm bandpass windows
(Fig. 2). However, the gated stained cell populations dis-
Forward vs. side scatter plot of equine PBMC suspension in  PBS Figure 1
Forward vs. side scatter plot of equine PBMC suspension in 
PBS. The cell subpopulation typically analysed for JC-1-asso-
ciated fluorescences is marked by the polygon area. Although 
more dispersed, a second subpopulation is readily visible.BMC Veterinary Research 2007, 3:25 http://www.biomedcentral.com/1746-6148/3/25
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played much more intense fluorescences in both windows
(Fig. 3), which yielded an excellent signal-to-noise ratio.
Among the ~120 stained cell populations of which the
results contributed to this study, there was never > 1% of
cells falling in the green autofluorescence window, show-
ing that the JC-1 concentration used is sufficient to stain
all cells despite the unavoidable slight variation of the
number of cells between cell suspensions. For the orange
autofluorescence, identical results were obtained,
excepted for a few cell suspensions intoxicated with CCCP
where up to 5% of the cells fell in the autofluorescence
window, which is attributable to the total dissipation of
the ∆ψm, thus of oligomers formation, in these cells. The
incorporation of CCCP led to the expected decrease of the
oligomer/monomer (orange/green) fluorescences ratio
(Fig. 4). Although 100 µM CCCP was used throughout the
study, a dose-response study made in 2 horses suggested
that maximal mitochondrial dysfunction is already
reached with 1 µM.
Afterwards, mean absolute fluorescence values and ratio
were measured in blood samples that had been kept at
room temperature for different durations before labora-
tory processing (Fig. 5). No differences were seen up to 5
hours (P > 0.05). Also, when horses were sampled several
times (1 to 35 days apart), the JC-1-associated fluores-
cence values retrieved from the corresponding PBMC pop-
ulations (Table 1, Fig. 6) remained unchanged (P > 0.05).
Regression of the orange/green ratio against age was not
significant and sex-specific means of the ratio with (0.06
± 0.01 in females vs. 0.06 ± 0.01 in neutered) and without
intoxication (0.63 ± 0.13 vs. 0.67 ± 0.07) were not differ-
ent (P > 0.05). Together, the 31 horses studied (Fig. 7)
have generated mean values that can be taken as refer-
ences : 42390 ± 8226 (monomer-associated fluores-
FL2 vs. FL1 scatter plot showing JC-1-associated fluores- cence emission of cell subpopulation gated like in Fig. 1, after  intoxication with the ∆ψm dissipator CCCP (100 µM) Figure 4
FL2 vs. FL1 scatter plot showing JC-1-associated fluores-
cence emission of cell subpopulation gated like in Fig. 1, after 
intoxication with the ∆ψm dissipator CCCP (100 µM).
FL2 vs. FL1 scatter plot showing autofluorescence emission  of cell subpopulation gated in Fig. 1 under 488 nm Sapphire™  solid-state laser excitation Figure 2
FL2 vs. FL1 scatter plot showing autofluorescence emission 
of cell subpopulation gated in Fig. 1 under 488 nm Sapphire™ 
solid-state laser excitation.
FL2 vs. FL1 scatter plot showing JC-1-associated fluores- cence emission of cell subpopulation gated like in Fig. 1 under  488 nm Sapphire™ solid-state laser excitation Figure 3
FL2 vs. FL1 scatter plot showing JC-1-associated fluores-
cence emission of cell subpopulation gated like in Fig. 1 under 
488 nm Sapphire™ solid-state laser excitation.BMC Veterinary Research 2007, 3:25 http://www.biomedcentral.com/1746-6148/3/25
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cence), 27385 ± 6391 (oligomer) and 0.64 ± 0.11
(oligomer/monomer ratio).
Discussion
A method for the quantitative analysis of mitochondrial
function in horse blood samples has been developed and
validated. After PBMC purification and resuspension in
PBS, cells are stained with JC-1 and analysed by flow
cytometry. To our knowledge, this is the first report of
mitochondrial function analysis with JC-1 in peripheral
blood cells. We have shown that the homogeneity of cell
staining and the signal-to-autofluorescence ratio are as
favourable as they were in cell lines [12,16]. Interestingly,
values measured after artificial intoxication are one order
of magnitude (10 ×) lower than values measured from
nontreated PBMC, which offers a large window to detect
even subtle mitochondrial function changes. With respect
to possible variation within each animal, we have shown
that a clinically healthy horse generates similar mitochon-
drial function values over time. More, these values are
independent of age and sex and were very homogeneous
among the cohort of horses enrolled. Taken together, the
present study therefore yields a reference value of mito-
Effect of time elapsed between blood sampling and start of  laboratory processing on equine PBMC JC-1 oligomer/mono- mer ratio Figure 6
Effect of time elapsed between blood sampling and start of 
laboratory processing on equine PBMC JC-1 oligomer/mono-
mer ratio. Seven horses were enrolled is this experimental 
setup (1, 7, 8, 10, 15, 16, 23). JC-1 oligomer/monomer ratios 
were calculated from mean fluorescences generated by 
10,000 PBMCs (without intoxication). Delay refers to 
elapsed time between blood sampling and its processing into 
the laboratory. * Mean oligomer/monomer ratio was signifi-
cantly different at 24 hours (P < 0.05).
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Table 1: Between-day reproducibility of JC-1 fluorescence in equine PBMC
Without intoxication With intoxication
Green* 
(monomer)
Orange* 
(oligomer)
Orange/green Green* 
(monomer)
Orange* 
(oligomer)
Orange/Green
DAY 1 (n = 8) 43785 ± 2421 28461 ± 4895 0.65 ± 0.08 22159 ± 2643 1426 ± 108 0.06 ± 0.01
DAY 2 (n = 8) 45288 ± 3290 27766 ± 3796 0.61 ± 0.09 25144 ± 5357 1618 ± 389 0.06 ± 0.01
DAY 3 (n = 4) 47075 ± 6895 30789 ± 5418 0.65 ± 0.02 31141 ± 13145 2160 ± 1067 0.07 ± 0.01
DAY 4 (n = 4) 42055 ± 4729 25426 ± 2591 0.61 ± 0.04 25886 ± 13145 1812 ± 1067 0.07 ± 0.01
Horses contributing to days 1 and 2 were 1, 7, 8, 10, 13, 15, 16, and 23. Horses contributing to the four days were 1, 7, 8 and 16.* mean 
fluorescence values of 10,000 PBMCs are given in arbitrary units. Analysis of variance did not reveal any significant effect of the day of measurement 
(p > 0.1).
individual changes of JC-1 oligomer/monomer mean fluores- cence ratio according to day of blood sampling Figure 5
individual changes of JC-1 oligomer/monomer mean fluores-
cence ratio according to day of blood sampling. Eight horses 
were enrolled is this experimental setup (1, 7, 8, 10, 11, 15, 
16, 23). JC-1 oligomer/monomer ratios were calculated from 
mean fluorescences generated by 10,000 PBMCs. There was 
no difference between days (P > 0.05).
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With intoxicationBMC Veterinary Research 2007, 3:25 http://www.biomedcentral.com/1746-6148/3/25
Page 5 of 7
(page number not for citation purposes)
chondrial function in equine PBMC, along with the calcu-
lation of the confidence interval in which 95% of healthy
horses are predicted to fall: 0.64 ± 0.22 (oligomer-to-
monomer ratio, mean ± 2SD). Should smaller animals,
such as dogs and cats, be assayed, histopaque columns
designed for smaller volumes must be used for purifica-
tion and the final concentration of mononuclear cells sus-
pensions should not be less than 200.000 per millilitre.
The starting point of this study consists in the compilation
of several morphologic clues suggesting that a subset of
equine myopathies might be attributable to mitochon-
drial dysfunction. These morphological suspicions have
to be confirmed by functional data to gain credibility.
Here, a new assay system is validated that, theoretically,
could bring such functional confirmation. By "theoreti-
cally", it is meant that the assay will prove to be useful if
and only if the mitochondrial dysfunction subjacent to a
said clinical syndrome simultaneously affects circulating
leucocytes. There is no relationship per se between myop-
athy and oxidative phosphorylation taking place in leuco-
Individual JC-1 oligomer- and monomer-associated fluores- cences and their ratio from PBMC retrieved from 31 clini- cally healthy horses Figure 7
Individual JC-1 oligomer- and monomer-associated fluores-
cences and their ratio from PBMC retrieved from 31 clini-
cally healthy horses.
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Table 2: Breed, age and sex of the 31 horses enrolled in the 
study
ID Breed Sex Age (yr)
1 Warm blood N 15
2 Warm blood N 16
3 Warm blood N 10
4 Warm blood F 5
5 Warm blood F 3
6 Warm blood N 19
7 Shire F 13
8 Warm blood F 14
9 Warm blood F 14
10 Warm blood F 6
11 Warm blood N 5
12 Warm blood F 7
13 Standard 
bred
F 14
14 Spanish 
horse
N 12
15 Warm blood N 5
16 Frisian F 7
17 Warm blood N 8
18 Warm blood F 22
19 Warm blood N 11
20 Warm blood F 10
21 Warm blood F 5
22 French 
saddle horse
F 17
23 Warm blood F 10
24 Warm blood M 7
25 Fjord F 14
26 Standard 
bred
F 1
27 Standard 
bred
F 1
28 Warm blood F 1
29 Cross-bred 
Arab horse
F 1
30 Warm blood F 2
31 Warm blood F 2
N, neutered; M, male; F, femaleBMC Veterinary Research 2007, 3:25 http://www.biomedcentral.com/1746-6148/3/25
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cytes, only the assumption that a mitochondrial
myopathy is probably a polysystemic disease rather than
a specific process affecting only the muscles. The polysys-
temic disease might clinically translate in a locomotor
syndrome just because of the higher mitochondrial den-
sity in oxidative muscles.
Conclusion
Whenever a quantitative measurement of mitochondrial
function in a horse is desired, blood samples should be
taken in sodium citrate tubes and kept at room tempera-
ture for a maximum of 5 hours before the laboratory pro-
cedure detailed here is started. This delay fits well with
most field conditions, provided the samples must not be
sent by post. We hope that the quantitative analysis of
mitochondrial function procedure validated here will
help in confirming, studying and preventing Equine Atyp-
ical Myopathy and toxic myopathies due to plant, bacte-
rial and fungal mitochondrial toxins.
Methods
Animals
A group of 31 clinically normal male, female or neutered
horses ranging between 8 months and 22 years of age,
were enrolled into the study (Table 2). All animals were
chosen at random. Eight of them were sampled on differ-
ent days in order to evaluate the overall reproducibility of
∆ψm measurements, i.e. the constancy of the orange/green
fluorescence ratio when day, JC-1 working solution and
laboratory handling are changed. In a second subset of
horses (n = 7), five tubes of venous blood were collected
at the same time. These tubes were kept at room tempera-
ture for variable durations (30 min., 90 min., 150 min., 5
h and 24 h) before laboratory processing was started,
which permitted to assess whether and to what extent the
delay between sampling and processing influences the
value targeted.
Chemicals
JC-1 (5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimida-
zolylcarbocyanine iodide) was from Molecular Probes
(Eugene, OR, USA) and carbonyl cyanide m-chlorophe-
nylhydrazone (CCCP) was purchased from Sigma-Aldrich
(Sigma Immunochemicals, St. Louis, MO, USA). Working
solutions, 200 µM (JC-1) and 50 µM (CCCP), both in
DMSO, were prepared and equilibrated to room tempera-
ture in advance.
Isolation of mononuclear cells
Five milliliters of venous blood was collected in BD Vacu-
tainer sodium citrate 0.105 M and kept at room tempera-
ture until processing. PBMC were separated from the
blood by layering it over histopaque (density: 1.077 ±
0.001) and centrifuging (1200 g for 20 min). The cell con-
tent and the purity of the preparations were checked by
visual inspection using light microscopy. The viability of
the cells was controlled by flow cytometry with propid-
ium iodide staining and was found to exceed 95%. For
flow cytometric PBMC autofluorescence and JC-1-associ-
ated fluorescence determinations, the mononuclear cells
were then suspended in azid-free PBS at a final concentra-
tion of ~106 cells per millilitre.
Visualization of changes in the ∆ψm
For each horse, one PBMC-containing 1 ml aliquot was
used for autofluorescence measurements, and two others
for ∆ψm determinations with or without intoxication with
the ∆ψm dissipator CCCP. JC-1 staining was as follows: 1
ml of the PBMC suspension in PBS was incubated at 37°C
for 10 min, stained with 10 µl of JC-1 working solution (2
µM final concentration) followed by another 25 min at
37°C under a carbon dioxide-enriched atmosphere (5%
in air). Cells were then washed and the pellet was resus-
pended in PBS for flow cytometric analysis. For intoxica-
tion, 2 µl of the CCCP working solution was incorporated
into the PBMC suspension during the first incubation
period (100 µM final concentration).
Flow cytometry
Autofluorescence and JC-1-dependent fluorescence
changes were recorded using a FACSCanto flow cytometer
(Becton-Dickinson) using 488 nm excitation with 530/30
nm (FL1, green) and 585/42 nm (FL2, orange) bandpass
emission filters. The reproducibility of the fluorescence
readings of the instrument was proven before all measure-
ments using fluorescein isothiocyanate- and R-phyco-
erythrin-labeled polymethylmethacrylate microspheres
(BD FACS 7-color Setup beads, Becton-Dickinson). The
sample flow rate was adjusted to about 1000 cells/s. For
one single analysis, the fluorescence properties of 10,000
mononuclear cells were collected. The respective gates
were defined using the distinctive forward-scatter and
side-scatter properties of the individual cell populations.
The data were analyzed using the FacsDIVA software (Bec-
ton-Dickinson). After JC-1 staining, there were always less
than 1 and 5% of cells within the green and orange prede-
fined autofluorescence intervals respectively.
Statistical analysis
The results are presented as means ± SD. Significant
changes were assessed by Student's t test. A value of P <
0.05 was accepted as the level of significance.
List of abbreviations
JC-1, 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimida-
zolylcarbocyanine iodide; ∆ψm, mitochondrial mem-
brane potential; CCCP, carbonyl cyanide m-
chlorophenylhydrazone; PBMC, peripheral blood mono-
nuclear cells; FSC, forward scatter; SSC, side scatter.Publish with BioMed Central    and   every 
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